Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/29/2012US20120077736 Inhibitor against forming biofilm comprising k-casein macropeptide
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120077706 Method for assaying protein-protein interaction
03/29/2012US20120077285 Layering for separating particles
03/29/2012US20120077284 Binding Surfaces for Affinity Assays
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120077269 Use of a protein in stem cell and cancer applications
03/29/2012US20120077249 Separation Of Virus And/Or Protein From Nucleic Acids By Primary Amines
03/29/2012US20120077248 Method for determining crystallization parameters and apparatus for use with the same
03/29/2012US20120077228 OVEREXPRESSION OF AMINOACYL-tRNA SYNTHETASES FOR EFFICIENT PRODUCTION OF ENGINEERED PROTEINS CONTAINING AMINO ACID ANALOGUES
03/29/2012US20120077226 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
03/29/2012US20120077187 Recombinant antigen for detection of toxocariasis
03/29/2012US20120076868 Cross-linked bioactive hydrogel matrices
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076826 Recombinantly Produced Allergens
03/29/2012US20120076816 Novel malaria vaccine
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076789 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
03/29/2012US20120076774 Detection and/or treatment of diseases associated with autoantibodies
03/29/2012US20120076771 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti-adhesion barriers and anti-thrombotic materials
03/29/2012US20120076724 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
03/29/2012CA2812724A1 Plants resistant to fungal pathogens and methods for production thereof
03/29/2012CA2812704A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof
03/29/2012CA2812380A1 Transgenic plants
03/29/2012CA2812153A1 Antigen-specific t cell receptors and t cell epitopes
03/29/2012CA2812096A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012CA2811797A1 Mosquitocidal xenorhabdus, lipopeptide and methods
03/29/2012CA2811788A1 Anti-ssx-2 t cell receptors and related materials and methods of use
03/29/2012CA2811734A1 Multimeric il-15 soluble fusion molecules and methods of making and using same
03/29/2012CA2811709A1 Improved process for production of recombinant human growth hormone
03/29/2012CA2811654A1 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions
03/29/2012CA2811243A1 Bvdv vaccine
03/29/2012CA2811023A1 Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
03/29/2012CA2809471A1 Process for production of fibrinogen
03/29/2012CA2808556A1 Therapeutic vaccination against active tuberculosis
03/28/2012EP2434024A1 Urine markers for detection of bladder cancer
03/28/2012EP2434023A1 Urine markers for detection of bladder cancer
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434019A1 Process for the production of fine chemicals
03/28/2012EP2434016A2 Expression of mammalian proteins in Pseudomonas fluorescens
03/28/2012EP2433964A1 Peptide inducing xage-1b-specific immune reaction and utilization of same
03/28/2012EP2433963A1 Receptor (SSTR2)-selective somatostatin antagonists
03/28/2012EP2433962A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433961A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433960A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433959A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433958A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433957A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433956A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433955A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433954A2 Identification of tumor-associated antigens for diagnosis and therapy
03/28/2012EP2433953A1 Cell membrane-permeable peptides
03/28/2012EP2433645A1 Novel malaria vaccine
03/28/2012EP2433639A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
03/28/2012EP2432893A1 Compositions, kits and methods for in vitro antigen presentation, assessing vaccine efficacy, and assessing immunotoxicity of biologics and drugs
03/28/2012EP2432892A1 Microorganism for expressing a human membrane protein
03/28/2012EP2432885A2 Methods for enhancing infectivity of retroviruses
03/28/2012EP2432874A1 Extracellular yaluronidase from streptomyces koganeiensis
03/28/2012EP2432864A2 Process to produce a wine or fruit juice stabiliser
03/28/2012EP2432802A1 Bifunctional polypeptides
03/28/2012EP2432500A2 Engineered type iv pilin of clostridium difficile
03/28/2012EP2432489A2 Variants of c-type natriuretic peptide
03/28/2012EP2432487A1 Inhibition of prion protein propagation by receptor associated protein (rap). its derivatives, mimetics and synthetic peptides
03/28/2012EP2432476A1 Methods for treating or preventing ophthalmological diseases
03/28/2012EP2114990B9 Method for predicting the response of NSCLC-patients to treatment by an EGFR-TK inhibitor
03/28/2012EP2112999B1 Non-natural recombinant gelatins with enhanced functionality
03/28/2012EP2021358B1 Modified bacteriocins and methods for their use
03/28/2012EP1978990B1 Compositions comprising igbpma and uses thereof
03/28/2012EP1919945B1 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof
03/28/2012EP1859041B1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier
03/28/2012EP1765362B1 Compositions and methods for treatment of neovascular diseases
03/28/2012EP1690870B1 Marker peptide for alzheimer's disease
03/28/2012EP1651667B1 Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
03/28/2012EP1569676B1 Calcitonin drug-oligomer conjugates, and uses thereof
03/28/2012EP1517700B1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/28/2012EP1283851B1 Use of il-4r antibodies and compositions thereof
03/28/2012EP1283716B1 Vaccine comprising a tick cement protein
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012EP1117684B1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
03/28/2012CN1931874B Preparation process, medicine preparation and medicinal use of ginseng glycopeptide
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395679A Methods and compositions for controlling plant pests
03/28/2012CN102395677A Method of screening for insulin secretion-potentiating agents
03/28/2012CN102395601A Method of producing polymers of spider silk proteins
03/28/2012CN102395600A Inactivated dengue virus vaccine with aluminium-free adjuvant
03/28/2012CN102395599A Modifications of cupredoxin derived peptides and methods of use thereof
03/28/2012CN102395377A Muscle function enhancing peptide
03/28/2012CN102392353A Finishing technology of chicken feather regenerated protein fabric printed and dyed cloth
03/28/2012CN102392049A Preparation method for hepatitis E virus antigen and product thereof
03/28/2012CN102392030A Recombinant human herpes simplex virus I protein and its application
03/28/2012CN102392029A Modified mcry2Ab4 gene and its application
03/28/2012CN102392026A Intramuscular adipose deposition FABP gene
03/28/2012CN102391374A Preparation method of active collagen with triple-helix structure
03/28/2012CN102391373A 4-aminoazobenzene complete antigen and its preparation method
03/28/2012CN102391372A Target of liver cancer drug therapy and application of the target
03/28/2012CN102391371A Protein for diagnosing and treating allergic disease and preparation method thereof
03/28/2012CN102391370A Antimicrobial peptides, preparation method and application thereof
03/28/2012CN102391369A Stress tolerance related 14-3-3 protein GRF9 and application thereof
03/28/2012CN102391368A Plant stress resistant protein AcTPR and application of AcTPR in gene coding
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 2916